# Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

> **NCT06330805** · PHASE2 · RECRUITING · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 70 (estimated)

## Conditions studied

- Prostate Adenocarcinoma
- Stage IIB Prostate Cancer AJCC v8
- Stage IIC Prostate Cancer AJCC v8

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Contrast Agent
- **DRUG:** Leuprolide
- **PROCEDURE:** Magnetic Resonance Imaging
- **OTHER:** Physical Performance Testing
- **DRUG:** Relugolix

## Key facts

- **NCT ID:** NCT06330805
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06330805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06330805, "Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06330805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*